Pharmaceuticals · Key players

Top Cancer Immunotherapy companies

The 5 key players our Cancer Immunotherapy report profiles, and other companies free public records show in this market.

Key players in Cancer Immunotherapy

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Cancer Immunotherapy market
#CompanyWebsiteOur reports
1 Merck & Co., Inc. merck.com (opens in a new tab) 1,320 reports
2 Bristol-Myers Squibb bms.com (opens in a new tab) 627 reports
3 Roche roche.com (opens in a new tab) 1,485 reports
4 AstraZeneca astrazeneca.com (opens in a new tab) 957 reports
5 Regeneron Pharmaceuticals regeneron.com (opens in a new tab) 429 reports

Also active in Cancer Immunotherapy

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Cancer Immunotherapy, from free public records
CompanyWhere public records show them
Beijing Biotech
Viatris
BioNTech
Kaleo Inc
Impax Laboratories Inc
Inmunotek S.L.
Teva Pharmaceutical
ImmunityBio, Inc.
Uswm
Avyxa Holdings
Shanghai Juncell Therapeutics
GSK PLC

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Cancer Immunotherapy

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Beijing Biotech 19 active trials on ClinicalTrials.gov (opens in a new tab)
  2. BioNTech 15 active trials on ClinicalTrials.gov (opens in a new tab)
  3. AstraZeneca 14 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Inmunotek S.L. 8 active trials on ClinicalTrials.gov (opens in a new tab)
  5. ImmunityBio, Inc. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Bristol-Myers Squibb 6 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Shanghai Juncell Therapeutics 6 active trials on ClinicalTrials.gov (opens in a new tab)
  8. GSK PLC 5 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Cancer Immunotherapy reports by place

All 33 places for Cancer Immunotherapy

Get the full Cancer Immunotherapy report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.